Statements in which the resource exists.
SubjectPredicateObjectContext
pubmed-article:2306741rdf:typepubmed:Citationlld:pubmed
pubmed-article:2306741lifeskim:mentionsumls-concept:C0086418lld:lifeskim
pubmed-article:2306741lifeskim:mentionsumls-concept:C0684249lld:lifeskim
pubmed-article:2306741lifeskim:mentionsumls-concept:C1711178lld:lifeskim
pubmed-article:2306741lifeskim:mentionsumls-concept:C0020200lld:lifeskim
pubmed-article:2306741lifeskim:mentionsumls-concept:C1519697lld:lifeskim
pubmed-article:2306741lifeskim:mentionsumls-concept:C0205132lld:lifeskim
pubmed-article:2306741lifeskim:mentionsumls-concept:C0301625lld:lifeskim
pubmed-article:2306741pubmed:issue6lld:pubmed
pubmed-article:2306741pubmed:dateCreated1990-4-12lld:pubmed
pubmed-article:2306741pubmed:abstractTextHybrid cell lines between HuT292-DM, a human lung carcinoma line resistant to 6-thioguanine and ouabain, and either normal human bronchial epithelial cells (NHBE) or an SV40 "immortalized" but nontumorigenic derivative thereof (BEAS-2B), have been isolated by double selection. Hybrids of NHBE and HuT292-DM cells senesced after 40-43 population doublings in culture. In contrast, hybrids of BEAS-2B and HuT292-DM showed no sign of a culture "crisis" and have an indefinite life span. HuT292-DM cells produced tumors in 100% of athymic nude mice with a mean latency of 27 days, whereas tumorigenicity was totally suppressed in 76% of the BEAS-2B x HuT292-DM hybrids, with a 2- to 3-fold increased tumor latency in the remaining 24% of these hybrids. While the hybrids are hypotriploid to hypotetraploid, the parental lines are hypodiploid. The growth of HuT292-DM cells is stimulated, whereas NHBE and BEAS-2B cells are inhibited by serum. The growth response of the BEAS-2B x HuT292-DM hybrids to serum is similar to that of HuT292-DM cells. Thus, tumorigenicity and culture longevity are dominantly controlled by the nontumorigenic parent (NHBE or BEAS-2B). On the other hand, serum responsiveness is more similar to that of the tumorigenic parent (HuT292-DM).lld:pubmed
pubmed-article:2306741pubmed:languageenglld:pubmed
pubmed-article:2306741pubmed:journalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:2306741pubmed:citationSubsetIMlld:pubmed
pubmed-article:2306741pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:2306741pubmed:statusMEDLINElld:pubmed
pubmed-article:2306741pubmed:monthMarlld:pubmed
pubmed-article:2306741pubmed:issn0008-5472lld:pubmed
pubmed-article:2306741pubmed:authorpubmed-author:KaighnM EMElld:pubmed
pubmed-article:2306741pubmed:authorpubmed-author:HarrisC CCClld:pubmed
pubmed-article:2306741pubmed:authorpubmed-author:GabrielsonE...lld:pubmed
pubmed-article:2306741pubmed:authorpubmed-author:ImanD SDSlld:pubmed
pubmed-article:2306741pubmed:authorpubmed-author:PaulsE AEAlld:pubmed
pubmed-article:2306741pubmed:issnTypePrintlld:pubmed
pubmed-article:2306741pubmed:day15lld:pubmed
pubmed-article:2306741pubmed:volume50lld:pubmed
pubmed-article:2306741pubmed:ownerNLMlld:pubmed
pubmed-article:2306741pubmed:authorsCompleteYlld:pubmed
pubmed-article:2306741pubmed:pagination1890-6lld:pubmed
pubmed-article:2306741pubmed:dateRevised2004-11-17lld:pubmed
pubmed-article:2306741pubmed:meshHeadingpubmed-meshheading:2306741-...lld:pubmed
pubmed-article:2306741pubmed:meshHeadingpubmed-meshheading:2306741-...lld:pubmed
pubmed-article:2306741pubmed:meshHeadingpubmed-meshheading:2306741-...lld:pubmed
pubmed-article:2306741pubmed:meshHeadingpubmed-meshheading:2306741-...lld:pubmed
pubmed-article:2306741pubmed:meshHeadingpubmed-meshheading:2306741-...lld:pubmed
pubmed-article:2306741pubmed:meshHeadingpubmed-meshheading:2306741-...lld:pubmed
pubmed-article:2306741pubmed:meshHeadingpubmed-meshheading:2306741-...lld:pubmed
pubmed-article:2306741pubmed:meshHeadingpubmed-meshheading:2306741-...lld:pubmed
pubmed-article:2306741pubmed:meshHeadingpubmed-meshheading:2306741-...lld:pubmed
pubmed-article:2306741pubmed:meshHeadingpubmed-meshheading:2306741-...lld:pubmed
pubmed-article:2306741pubmed:meshHeadingpubmed-meshheading:2306741-...lld:pubmed
pubmed-article:2306741pubmed:meshHeadingpubmed-meshheading:2306741-...lld:pubmed
pubmed-article:2306741pubmed:meshHeadingpubmed-meshheading:2306741-...lld:pubmed
pubmed-article:2306741pubmed:meshHeadingpubmed-meshheading:2306741-...lld:pubmed
pubmed-article:2306741pubmed:meshHeadingpubmed-meshheading:2306741-...lld:pubmed
pubmed-article:2306741pubmed:year1990lld:pubmed
pubmed-article:2306741pubmed:articleTitleSuppression of tumorigenicity of a human lung carcinoma line by nontumorigenic bronchial epithelial cells in somatic cell hybrids.lld:pubmed
pubmed-article:2306741pubmed:affiliationLaboratory of Human Carcinogenesis, National Cancer Institute, Bethesda, Maryland 20892.lld:pubmed
pubmed-article:2306741pubmed:publicationTypeJournal Articlelld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:2306741lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:2306741lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:2306741lld:pubmed